Live Breaking News & Updates on Business Development At Peprotech Inc|Page 1

Kadimastem hopes to turn corner with new management
The Israeli stem cell technology company has named Asaf Shiloni CEO, after three new expert directors joined its board.
Israeli stem cell technology company Kadimastem (TASE: KDST) has had a chequered history, with frequent going concern warnings on its financials, a downward drifting share price from its 2016 peak, and the departure last year of founder and CEO Yossi Ben-Yosef. The company now hopes to have turned a corner with the appointment of a new and experienced CEO and new directors.
Kadimastem has named Asaf Shiloni, who was Vice President of Sales and Business Development at California-based PeproTech Inc., as CEO. PeproTech is the leading manufacturer of GMP Cytokines, vital components in all stem cell and cell therapy clinical trials. Kadimastem s announcement states that at PeproTech Shiloni established collaborations and joint ventures with top US stem cell companies and leading research labs worldwide, ....

United States , Tel Aviv , Doron Birger , Bioblast Pharma Nasdaq , Ronen Twito , Ron Mayron , Yossi Ben Yosef , Asaf Shiloni , Peprotech Shiloni , College Of Management , Business Development At Peprotech Inc , Elron Electronic Industries Ltd , Tel Aviv Stock Exchange , Tel Aviv University , Teva Pharmaceutical Industries Ltd , Vice President , Business Development , California Based Peprotech Inc , Computer Information Systems , Amplify Capital , Cellect Biotechnology , Bioblast Pharma , Given Imaging , Elron Electronic Industries , Teva Pharmaceutical Industries , Teva Israel ,